High throughput screening Market Overview

High throughput screening (HTS) is a drug discovery process generally utilized in the pharmaceutical companies to influence the mechanization that can rapidly examine the natural or biochemical action of an expansive number of medications. Since HTS allows assaying of a large number of potential biological modulators against a chosen set of defined targets, it has acquired the status of a popular approach to the target validation.

Over the past few years, the High throughput screening market is growing pervasively mainly due to the burgeoning pharmaceutical industry and the widening adoption of the HTS in the drug discovery. Furthermore, the increasing per capita health care expenditures, backed by the improving economic conditions, worldwide, are escalating the market on the ascended heights, increasing the demand for the quality healthcare treatments.

Soaring Investments in the healthcare sector and the shift towards high throughput research propels the growth of the high throughput satellite. The market is largely driven by target identification validation, efficacy safety screening, and monitoring of cell-based activity.

Additional factors supporting the market growth include the huge uptake of open innovation models by pharmaceutical companies, substantiating the use of high-throughput screening, rising drug discovery initiatives by academic and government institutions, boosting the demand for HTS products, and increasing capital investments in high-throughput screening technology by major firms.

High throughput screening Market Segmentation

The MRFR analysis is segmented into four key dynamics for the convenience of understanding.

  • By Product Type:Software, Instruments, and Consumables among others.
  • By Application:Target Identification, Primary Screening, Toxicology, and Stem Cell Biology, among others.
  • By End-user:Hospitals, Clinics, Pharmaceutical Companies/ Manufacturers, Government Organizations, and Research Facilities among others.

Global High throughput screening Market — Geographical Analysis

The subsegment Instruments by product types is expected to witness significant growth in demand due to its increasing use in drug discovery processes, superior performance, and reduced system cost.

Owing to the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications, the subsegment pharmaceutical, and biotechnology companies acquired the largest share in the global HTS market, by end users.

High throughput screening Market Key player

The market leaders profiled in the MRFR analysis include Beckman Coulter, Inc., Aurora Biomed Inc., Agilent Technologies Inc., Luminex Corporation, Life Technologies Corporation, Roche, Bio-Rad Laboratories, Sigma-Aldrich Corporation, and Thermo Fisher Scientific, Inc.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: info@marketresearchfuture.com